Shuling Zhang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Shuling Zhang

Showing results (131-140 of 134) with videos related to

Pageof 14

Sort By:

You have reached the last page of results.This site can display upto 134 results.

Molecular Cancer Therapeutics|May 20, 2017

Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC DegradationJohn K Simmons, Aleksandra M Michalowski, Benjamin J Gamache, et al.

Molecular Cancer Therapeutics|August 5, 2020

Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL TumorigenesisJoy M Gary, John K Simmons, Jinfei Xu, et al.

Nature Communications|November 15, 2017

mTOR intersects antibody-inducing signals from TACI in marginal zone B cellsJordi Sintes, Maurizio Gentile, Shuling Zhang, et al.

Cancer Letters|June 25, 2023

Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myelomaTyler J Peat, Snehal M Gaikwad, Wendy Dubois, et al.

Pageof 14

Search research articles

Showing results (131-140 of 134) with videos related to

Sort By:

Pageof 14

You have reached the last page of results.This site can display upto 134 results.

Molecular Cancer Therapeutics|May 20, 2017

Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC DegradationJohn K Simmons, Aleksandra M Michalowski, Benjamin J Gamache, et al.

Molecular Cancer Therapeutics|August 5, 2020

Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL TumorigenesisJoy M Gary, John K Simmons, Jinfei Xu, et al.

Nature Communications|November 15, 2017

mTOR intersects antibody-inducing signals from TACI in marginal zone B cellsJordi Sintes, Maurizio Gentile, Shuling Zhang, et al.

Cancer Letters|June 25, 2023

Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myelomaTyler J Peat, Snehal M Gaikwad, Wendy Dubois, et al.

Pageof 14